Cancer Diagnosis and Treatment
Cancer Diagnosis and Treatment is a research topic within Oncology. Science Explorer counts 41k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and molecular characterization of Cancer of Unknown Primary (CUP) site. It includes research on metastatic patterns, molecular profiling to identify tissue of origin, immunohistochemical markers, diagnostic algorithms, and clinical management strategies.
- Cancer of Unknown Primary
- Metastasis
- Tissue of Origin
- Molecular Profiling
- Immunohistochemistry
- Diagnostic Algorithm
- Soft Tissue Metastases
- Gene Expression Profiling
- Unknown Primary Tumours
- Clinical Management
- Research works
- 41k fractional, since 1950
- In the world top 10%
- 4.3k per year above
- Top-10% rate
- 10.4% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- -9% the tick is no change
- Largest producer
United States
33% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cancer Diagnosis and Treatment research?
By volume, the United States and China publish the most (1.4k and 638 works in 2022-now).
By volume, 2022-now
- 1
United States 1.4k works
- 2
China 638 works
- 3
India 513 works
- 4
Japan 457 works
- 5
United Kingdom 275 works
- 6
Germany 235 works
- 7
Italy 198 works
- 8
Spain 184 works
- 9
Brazil 172 works
- 10
Türkiye 164 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer Diagnosis and Treatment research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Cancer Diagnosis and Treatment research, followed by Harvard University and The University of Texas MD Anderson Cancer Center.
By volume, 2022-now
- 1
All India Institute of Medical Sciences
India 53 works
- 2
Harvard University
United States 45 works
- 3
The University of Texas MD Anderson Cancer Center
United States 36 works
- 4
Mayo Clinic
United States 31 works
- 5
Memorial Sloan Kettering Cancer Center
United States 27 works
- 6
Sun Yat-sen University
China 24 works
- 7
Peking University
China 21 works
- 8
Sichuan University
China 20 works
- 9
Cleveland Clinic
United States 20 works
- 10
Chinese Academy of Medical Sciences & Peking Union Medical College
China 19 works
Who are the leading researchers in Cancer Diagnosis and Treatment?
The most-cited researchers publishing on Cancer Diagnosis and Treatment include Ahmedin Jemal, Eric S. Lander and Elaine R. Mardis.
- 1
Ahmedin Jemal
United States 761k citations
- 2
Eric S. Lander
United States 524k citations
- 3
Elaine R. Mardis
United States 346k citations
- 4
Hermann Brenner
Germany 343k citations
- 5
Cyrus Cooper
United Kingdom 342k citations
- 6
Robert A. Weinberg
United States 301k citations
- 7
Todd R. Golub
United States 283k citations
- 8
Reza Malekzadeh
Iran 278k citations
- 9
Gordon Brent Mills
United States 265k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer Diagnosis and Treatment research done?
The largest centres of Cancer Diagnosis and Treatment research in 2022-now are New York (United States), Tokyo (Japan), Beijing (China) and London (United Kingdom).
Largest cities, 2022-now
- 1
New York
United States 79 works
- 2
Tokyo
Japan 79 works
- 3
Beijing
China 79 works
- 4
London
United Kingdom 70 works
- 5
Seoul
South Korea 59 works
- 6
Moscow
Russia 59 works
- 7
Shanghai
China 58 works
- 8
Houston
United States 54 works
- 9
Istanbul
Türkiye 53 works
- 10
New Delhi
India 53 works
Where is the best place to study Cancer Diagnosis and Treatment?
Among universities, judged by research, Harvard University, University of California, San Francisco and Heidelberg University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Cancer Diagnosis and Treatment, country by countryIs Cancer Diagnosis and Treatment research growing?
Output in 2022-2025 was 9% lower than in 2018-2021, peaking in 2020.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Cancer Diagnosis and Treatment as a percentage of every work published that year, 0.029% in 2024.
Fractional works of Cancer Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Cancer Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.